The Nobel Prize in Physiology or Medicine 2015 went (partial) to the Chinese Youyou Tu for the discovery of artemisinin as an anti-malarial drug. Pierre Lutgen explains that the Serbs described the use of artemisinin before the Chinese did… Read the blog “Artemisinin first discovered by the Serbs long before the Chinese” here.
Artemisinin, however, is not yet available to all in need. It is very costly to extract and purify the drug from Artemisia annua. A study, published on 20 October in Molecular Plant, now demonstrates that the tobacco plant can be engineered to synthesise artemisinin. Will this become an affordable alternative anti-malaria drug? Read The Molecular Plant article “Compartmentalized Metabolic Engineering for Artemisinin Biosynthesis and Effective Malaria Treatment by Oral Delivery of Plant Cells” here.
Reminder deadline EOI promotion of south-centred collabotations in VBD's
Kindly be reminded that the deadline for the EOI regarding the promotion of south-centred collabotations in vector-borne diseases is approaching (3rd November). If you are interested to contrube then read the full announcement ‘Promoting south-centred collaborations in vector-borne diseases’ here.
Enjoy this week's MalariaWorld - the MW team
Support MalariaWorld to provide Open Access to malaria information for all. We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at firstname.lastname@example.org
MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.
Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to www.malariaworld.org, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.
This infographic displays data from the World Health Organization’s “Projections of mortality and causes of death, 2015 and 2030”. The report details all deaths in 2015 by cause and makes predictions for 2030, giving an impression of how global health will develop over the next 14 years. Also featured is data from geoba.se showing how life expectancy will change between now and 2030.
SciDev.Net article - 21-09-2016
illumigene® Malaria, a novel, highly accurate test developed by Meridian Bioscience, has been awarded the coveted Journées Internationales de Biologie prize for Innovation in emergency treatment and point of care testing.
I am delighted to welcome Dr Fred Binka as Coordinator of WHO’s Emergency Response to Artemisinin Resistance (ERAR) hub in Phnom Penh, Cambodia.
Dear Partners and Friends,
After a period of extensive consultation, the RBM Board agreed at its 29th Meeting in December 2015 on a new governance architecture. This included the establishment of a reconstituted Partnership Board, which could take advantage of the tremendous skill, energy and effectiveness of its partners and lead the organization into a new era.
Dr Sylvia Meek meets with community drug distributors supported by our integrated community case management and nutrition project
ACT Consortium launches free resources for malaria community
On World Malaria Day, ACT Consortium researchers launched five resources to help guide those working in malaria endemic countries.
WHO Director-General Margaret Chan thanks Switzerland for their engagement in the fight against malaria via video message on World Malaria Day 2016 in Bern, Switzerland.